CorMedix appoints Robert Stewart to Board of Directors

CorMedix Inc.

Robert Stewart appointed to Board effective April 13, 2023; Board now has 8 directors, 7 independent.
Stewart is CEO of Theramex; former CEO of Amneal Pharma and COO of Allergan.
Received initial option for 25,000 shares (1/3 vesting at grant, then annually); additional prorated option for 14,200 shares.
Stewart's experience expected to aid CorMedix's transition from development to commercial phase, per CEO.
Press release highlights commercial potential for lead product DefenCath.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert Stewart

Director

CRMD · CorMedix Inc.

Effective: 2023-04-13
Filed: April 17, 2023, 7:59 PM ET

On April 13, 2023, the Board of Directors (the “Board”) of CorMedix Inc. (the “Company”) appointed Robert Stewart as a director, effective immediately

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Robert Stewart was appointed as Director at CorMedix Inc..

Action: appointed
Role: Director

Exact text from the filing

On April 13, 2023, the Board of Directors (the “Board”) of CorMedix Inc. (the “Company”) appointed Robert Stewart as a director, effective immediately

View on SEC.gov

CorMedix Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-030043

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.